ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 166 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $68,000 | -16.0% | 15,842 | +13.5% | 0.00% | 0.0% |
Q2 2019 | $81,000 | -65.5% | 13,952 | -67.3% | 0.00% | -66.7% |
Q2 2016 | $235,000 | -67.1% | 42,723 | -55.7% | 0.00% | -62.5% |
Q1 2016 | $715,000 | -21.9% | 96,406 | -12.5% | 0.01% | -20.0% |
Q4 2015 | $915,000 | -22.1% | 110,163 | +1.0% | 0.01% | +11.1% |
Q1 2015 | $1,175,000 | – | 109,080 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |